html Omega-3 and women's health | Omega-3 Science
Content based on scientific studies and verifiable data.Updated: September 2026
Women's health

Omega-3 and women's health: from the reproductive years to pregnancy

EPA and DHA participate in hormonal, inflammatory and structural pathways that become important at different stages of a woman's life, with particularly strong evidence in pregnancy and fetal development.

Key areas

Where the evidence is most relevant

Pregnancy has the strongest evidence base; PCOS and dysmenorrhoea add evidence in specific contexts.

9m

Preterm birth

Large reviews and trials show a reduction in preterm birth, especially when baseline omega-3 status is low.

DHA

Fetal brain and retina

DHA is structural material for the brain and retina during fetal development.

↔

Mother-to-baby transfer

Maternal supplementation increases DHA in the mother, breast milk and the baby's membranes.

SOP

Metabolic profile in PCOS

Reviews of RCTs found improvements in some metabolic and hormonal markers in women with polycystic ovary syndrome.

♀

Menstrual pain

Randomised trials found reduced dysmenorrhoea intensity and less need for rescue ibuprofen.

%

Test status

In pregnancy, ORIP studies showed that baseline status helps identify who has the greatest room to benefit from higher doses.

In women's health, some topics extend into other areas of the site: DHA links pregnancy to brain and the retina, while inflammatory balance connects to the page on chronic low-grade inflammation.

Pregnancy

The largest body of data is on preterm birth

The 2018 Cochrane review included 70 trials and nearly 20,000 women.

70 RCTs

19.927 women included in the review.

Birth <37 weeks

Approximate reduction of 11% across the trials.

Birth <34 weeks

Approximate reduction of 42% for early preterm birth.

PMID 30480773 →Related scientific study
ORIP

Baseline status changes the interpretation

ORIP and subsequent analyses showed that the benefit of higher doses was concentrated mainly in women with low baseline status.

ORIP

Large-scale Australian trial of prenatal omega-3 supplementation.

PMID 31509674 →Related scientific study

Low baseline

The exploratory analysis showed a marked reduction in birth before 34 weeks in the group with low baseline status.

PMID 32034969 →Related scientific study

Test and treat

Later work went further in identifying the women who may benefit from a higher dose.

PMID 37068907 →Related scientific study
Other stages

PCOS and menstrual pain also have human data

SOP

Meta-analyses and RCTs show improvements in insulin-resistance markers and some hormonal indicators in women with PCOS.

PMID 39275277 →Related scientific study

Dysmenorrhoea

In a double-blind crossover study, omega-3 reduced pain intensity and the need for rescue ibuprofen.

PMID 22261128 →Related scientific study

Adolescents

A classic RCT also found improvement in dysmenorrhoea symptoms with omega-3 supplementation.

PMID 8623866 →Related scientific study
Presentation available in the Library

Prefer this topic as a presentation?

Open the material page to view the visual version, related references and the reviewed PDF for reading or sharing.

View women's health materials →